Skip to content
Search
Sectoral / ThematicVery High RiskSBI Mutual Fund

SBI Healthcare Opportunities Fund

Portfolio as on Sep 2026 · 35 equity positions

Equity positions
35
Equity value
₹5,608 Cr
Top holding
11.14%
Sun Pharmaceutical Industries Ltd
NAV per unit
₹393.42
Sep 2026
Avg AUM
₹5,565 Cr
Expense ratio
1.02% p.a.
Fund manager
Tanmaya Desai
Own another fund too? See how much they overlap →

The portfolio at a glance

SBI Healthcare Opportunities Fund is a Sectoral / Thematic scheme from SBI MF. Its Sep 2026 portfolio holds 35 stocks, and its average assets under management are ₹5,565 Cr.

Its largest position is Sun Pharmaceutical Industries at 11.14% of the portfolio, and the ten largest together make up 51.83%.

By sector, Pharmaceuticals & Biotechnology is the largest at 66.03% of the equity portfolio, followed by Healthcare Services (26.86%) and Chemicals & Petrochemicals (5.20%).

Hold other funds too? The fund overlap tool shows how many of these stocks they share. A scheme's official riskometer is in its factsheet on the fund house's website.

NAV history

₹414 per unit +17.9% vs Oct '25

Last 365 days · daily NAV from AMFI · SBI Healthcare Opportunities Fund

₹316₹452₹587Oct '25Dec '25Mar '26Jun '26Sep '26

Performance & risk

Annualized return
+20.2%
Volatility
170.4%
Sharpe ratio
0.08
Beta
0.43
weak fit — 25% of moves
Alpha
+16.9%
vs. benchmark, annualized

Based on ~11 months of weekly NAV history from AMFI. Volatility is the annualized standard deviation of NAV returns. Sharpe ratio and alpha assume a 6.5% risk-free rate. Beta measures how much the fund moves with its benchmark (1.0 = in step); alpha is the return above what that beta would predict. Measured against the NAV of Kotak Nifty 50 Index Fund, standing in for the NIFTY 50 itself. A tracker's NAV is the index minus its running costs, so this compares funds against an investable benchmark rather than a costless one. Past performance does not guarantee future returns — not investment advice.

Sector allocation

Pharmaceuticals & Biotechnology: 66% · ₹3,703 Cr · 20 fundsHealthcare Services: 27% · ₹1,506 Cr · 12 fundsChemicals & Petrochemicals: 5% · ₹291 Cr · 2 fundsHealthcare Equipment & Supplies: 2% · ₹107 Cr · 1 funds
35stocks
  • Pharmaceuticals & Biotechnology66%
  • Healthcare Services27%
  • Chemicals & Petrochemicals5%
  • Healthcare Equipment & Supplies2%

Top holdings

Top 10 holdings make up 51.8% of the portfolio · top 5 = 33.0%.

35 stocks
#
1Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology₹653.98 Cr
11.14%
2Divi's LaboratoriesPharmaceuticals & Biotechnology₹464.58 Cr
7.91%
3Acutaas ChemicalsPharmaceuticals & Biotechnology₹295.15 Cr
5.03%
4Apollo Hospitals EnterpriseHealthcare Services₹261.30 Cr
4.45%
5Torrent PharmaceuticalsPharmaceuticals & Biotechnology₹259.20 Cr
4.42%
6CiplaPharmaceuticals & Biotechnology₹258.43 Cr
4.40%
7Laurus LabsPharmaceuticals & Biotechnology₹237.60 Cr
4.05%
8Max Healthcare InstituteHealthcare Services₹223.15 Cr
3.80%
9Aurobindo PharmaPharmaceuticals & Biotechnology₹200.64 Cr
3.42%
10Aster DM Quality CareHealthcare Services₹188.23 Cr
3.21%
11Gland PharmaPharmaceuticals & Biotechnology₹173.96 Cr
2.96%
12Sudeep PharmaChemicals & Petrochemicals₹163.99 Cr
2.79%
13Anthem BiosciencesPharmaceuticals & Biotechnology₹161.42 Cr
2.75%
14Sai Life SciencesPharmaceuticals & Biotechnology₹152.45 Cr
2.60%
15Corona RemediesPharmaceuticals & Biotechnology₹142.35 Cr
2.43%
16BioconPharmaceuticals & Biotechnology₹138.86 Cr
2.37%
17Fortis HealthcareHealthcare Services₹138.60 Cr
2.36%
18Concord BiotechPharmaceuticals & Biotechnology₹131.87 Cr
2.25%
19Aether IndustriesChemicals & Petrochemicals₹127.45 Cr
2.17%
20Jupiter Life Line HospitalsHealthcare Services₹126.80 Cr
2.16%
21Poly MedicureHealthcare Equipment & Supplies₹107.12 Cr
1.82%
22Ajanta PharmaPharmaceuticals & Biotechnology₹104.93 Cr
1.79%
23Global HealthHealthcare Services₹102.38 Cr
1.74%
24Mankind PharmaPharmaceuticals & Biotechnology₹100.15 Cr
1.71%
25Healthcare Global EnterprisesHealthcare Services₹99.91 Cr
1.70%
26Krishna Institute Of Medical SciencesHealthcare Services₹99.36 Cr
1.69%
27Cohance LifesciencesPharmaceuticals & Biotechnology₹97.68 Cr
1.66%
28Innova CaptabPharmaceuticals & Biotechnology₹96.64 Cr
1.65%
29Dr. Lal Path labsHealthcare Services₹95.38 Cr
1.62%
30Nephrocare Health Service Pvt.Healthcare Services₹65.98 Cr
1.12%
31Syngene InternationalHealthcare Services₹65.75 Cr
1.12%
32Rainbow Childrens MedicareHealthcare Services₹39.43 Cr
0.67%
33Gufic BiosciencesPharmaceuticals & Biotechnology₹17.28 Cr
0.29%
34Abbott IndiaPharmaceuticals & Biotechnology₹13.56 Cr
0.23%
35Novartis IndiaPharmaceuticals & Biotechnology₹2.34 Cr
0.04%

SBI Healthcare Opportunities Fund — FAQ

What are the top holdings of SBI Healthcare Opportunities Fund?
SBI Healthcare Opportunities Fund holds 35 equity positions; the largest is Sun Pharmaceutical Industries Ltd at 11.14% of the portfolio, as on Sep 2026. Information only, not investment advice.
How concentrated is SBI Healthcare Opportunities Fund?
Its single largest equity position is Sun Pharmaceutical Industries Ltd, at 11.14% of the fund's disclosed portfolio.
As of when is this SBI Healthcare Opportunities Fund portfolio?
Portfolio as on Sep 2026, taken from SBI Mutual Fund's public monthly portfolio disclosure.
What is the NAV of SBI Healthcare Opportunities Fund?
The latest NAV (Net Asset Value) of SBI Healthcare Opportunities Fund is ₹393.42 per unit, as on Sep 2026, sourced from AMFI's public scheme data. NAV changes daily with market movements. Information only, not investment advice.
What is the AUM of SBI Healthcare Opportunities Fund?
SBI Healthcare Opportunities Fund has a Monthly Average AUM (Assets Under Management) of ₹5,565 Cr, as per AMFI's latest published data. AUM reflects the total market value of all assets managed across all plans of this scheme. Information only, not investment advice.
Who manages SBI Healthcare Opportunities Fund?
SBI Healthcare Opportunities Fund is managed by Tanmaya Desai, as per AMFI's public disclosure. Fund manager details sourced from Kuvera/AMFI data. Information only, not investment advice.
What is the expense ratio of SBI Healthcare Opportunities Fund?
SBI Healthcare Opportunities Fund has a Total Expense Ratio (TER) of 1.02% p.a., as disclosed to AMFI. The TER is the annual cost of running the fund, deducted daily from the NAV. A lower TER means more of the fund's return flows to investors. Information only, not investment advice.
What is the 1-year NAV return of SBI Healthcare Opportunities Fund?
SBI Healthcare Opportunities Fund's NAV moved from ₹351.37 (Oct 2025) to ₹414.29 (Sep 2026), a change of 17.9% over approximately one year. NAV data sourced from AMFI. Past performance is not indicative of future returns. Information only, not investment advice.
What is the Sharpe ratio of SBI Healthcare Opportunities Fund?
Based on roughly 11 months of NAV history, SBI Healthcare Opportunities Fund has an annualized return of about 20.2% with 170.4% annualized volatility, giving a Sharpe ratio of 0.08 (assuming a 6.5% risk-free rate). A higher Sharpe ratio means more return per unit of risk taken. Past performance is not indicative of future returns.
What are the beta and alpha of SBI Healthcare Opportunities Fund?
SBI Healthcare Opportunities Fund has a beta of 0.43 and an annualized alpha of +16.9%. Beta measures how much the fund moves with its benchmark — 1.0 means it moves in step, above 1.0 amplifies it. Alpha is the return above what that beta would predict. Measured against the NAV of Kotak Nifty 50 Index Fund, standing in for the NIFTY 50 itself. A tracker's NAV is the index minus its running costs, so this compares funds against an investable benchmark rather than a costless one. Alpha assumes a 6.5% risk-free rate. The benchmark explains 25% of this fund's movement, which is low — the beta is correctly computed but says little about a fund this different from the index. Past performance is not indicative of future returns. Information only, not investment advice.

Similar funds

How much does SBI Healthcare Opportunities overlap with ICICI Technology? →

Equity holdings only, ISIN-verified, from SBI Mutual Fund's public monthly portfolio disclosure (Sep 2026). Not investment advice.
Weight = the position as a % of this fund's portfolio. Values in ₹: L = Lakh (1,00,000), Cr = Crore (1,00,00,000).